Akriderm SK ointment for external use 15g
Condition: New product
1000 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Betamethasone + Salicylic Acid
Release form
Ointment
Composition
100 g of betamethasone dipropionate 64 mg salicylic acid 3 g. Excipients: magnesium stearate, polyvidone, sodium starch glycolate, microcrystalline cellulose. The composition of the film shell: titanium dioxide, talc, hypromellose.
Pharmacological effect
Pharmacokinetics
Indications
The combination of corticosteroids with an antiseptic with keratolytic action.
Contraindications
The drug Akriderm SK is applied with a thin layer on the inflamed surface 2 times / day, slightly rubbing. In milder cases, single use is sufficient. The duration of treatment is usually limited to 3 weeks. If necessary, a long course of therapy is recommended to use the drug less often, for example, every other day. In the treatment of chronic diseases under the constant supervision of a physician, treatment should continue for some time after the disappearance of all symptoms in order to avoid recurrence of the disease. The use of the drug in children under 12 years of age is carried out under the supervision of the attending physician.
Use during pregnancy and lactation
Ointment Akriderm SK is intended only for external use on the skin. The drug should not be applied to the skin near the eyes. Long-term use on the skin of the face is not recommended due to the possible development of dermatitis like rosacea, perioral dermatitis, skin atrophy and acne. The use of the drug in the anogenital area should be avoided.
Dosage and administration
Ointment Akriderm SK is used for the treatment of subacute and chronic dermatoses, sensitive to external corticosteroid therapy, accompanied by hyperkeratosis: - psoriasis. - atopic dermatitis (neurodermatitis). - lichen planus. - eczema. - dyshydratic dermatitis. - ichthyosis and ichthyosoform changes.
Side effects
No clinically significant interactions with other drugs.
special instructions
No clinically significant interactions with other drugs.